$MSCI

Morgan Stanley raises MSCI stock price target to $671 on strong sales growth

Morgan Stanley raised its price target for MSCI (NYSE:MSCI) to $671, citing strong sales growth and performance across its business segments. The company reported 12% revenue growth and an 83% gross profit margin over the last year. Several analysts have increased their price targets following MSCI's strong Q3 2026 earnings, which exceeded expectations.

Original reporting
Published Oct 21, 2026, 11:06 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 21, 2026, 11:28 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$MSCI
Bullish
high confidence
Mentioned
$MSCI
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$MSCIBullishHigh
01

Why it matters

The earnings beat and target hikes are likely to attract buying interest, supporting short-term price appreciation.

02

Market read

MSCI's earnings beat and multiple analyst upgrades present a clear bullish catalyst for the stock.

03

What to watch

Potential macro headwinds or valuation concerns given MSCI's high P/E may limit upside.

Relevance 8/10Novelty 8/10Timing: after-hours reaction

Background

Analyst upgrades follow MSCI's strong quarterly performance, highlighting growth across its index, analytics, and private assets segments.

Company-level read

Ticker impact

$MSCIBullishHigh confidence
Context

MSCI reported Q3 2026 earnings beating expectations with $5.11 EPS and $892M revenue, prompting multiple analysts to raise price targets.

Expected impact

upward pressure as the market prices in the earnings beat and higher analyst targets

Evidence & confidence

Strong revenue growth and EPS beat, combined with multiple target raises, typically drive the stock higher in the short term.

Market effects

Positive earnings may lift the broader financial data and analytics sector.

U.S. markets may see a modest gain in related index components.

International investors tracking MSCI indices may adjust exposure.

Counterpoint

If the price targets are already priced in, the stock could face a pullback on profit-taking.

Key entities

  • Morgan Stanley

    Raised price target to $671 and maintained Overweight rating.

  • Goldman Sachs

    Raised price target to $684.

Related articles

$MSMMed

MSCI Industrial Direct (MSM) Reports Strong Q4 Sales Growth and

MSCI Industrial Direct (MSM) reported Q4 2026 sales of $1.1B, up 8.6% daily average. Adjusted operating margin improved to 10.9%. The company declared a 3.09% dividend yield with an 81% payout ratio. GF Value™ suggests a 20.6% overvaluation. Insiders bought $18M in shares over 12 months. MSM's GF Score™ is 75/100, with strengths in financial health and momentum but weaker growth and valuation.

$ACNHighAI 8/10

These 3 Stocks Surged Following Strong Quarterly Results

Accenture (ACN), Hasbro (HAS), and MSCI (MSCI) reported strong Q3 earnings, driving their shares higher. ACN revenue rose 6% YoY to $18.7B, exceeding guidance. HAS revenue increased 15% YoY to $1.6B, with Magic: The Gathering sales surpassing $600M. MSCI reported 14% YoY earnings growth to $5.11 per share, with record asset-based fees.

$MSCIHighAI 8/10

MSCI SWOT Analysis: Strong Profitability and Growth Potential Re

MSCI Inc. reported Q3 2026 operating revenues of $892.0M, up from $793.4M in Q3 2025. Nine-month revenues reached $2.609B. The company has a GF Score of 94/100, with a GF Value of $721.12, suggesting 17.9% undervaluation. Strengths include diversified products and strong profitability, while weaknesses include financial strength rated 4/10 and reliance on a concentrated client base.

$MSCIMedAI 8/10

MSCI (MSCI) Q3 2026 Earnings Call Transcript

MSCI reported Q3 2026 earnings with total revenue growth of 12.4%, adjusted EBITDA growth of 12%, and adjusted EPS growth of 14%. The company repurchased $627 million of shares and saw record ABF run rate of nearly $1 billion. MSCI also announced partnerships and acquisitions to expand its offerings, with strong demand across various client segments and regions.